Kidney cancer: open trials in Chile

• NCT07489495

  A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  IC La Serena Research (Site 0405), La Serena · Clínica Puerto Montt (Site 0404), Port Montt · Fundacion Arturo Lopez Perez (Site 0401), Santiago · Bradfordhill (Site 0400), Santiago · ONCOCENTRO APYS (Site 0403), Viña del Mar

  Registry updated 2026-10-29

• NCT07049926

  Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Centro de Estudios Clínicos SAGA (Site 6110), Santiago · Bradfordhill (Site 6101), Santiago · CDIEM (Site 6114), Santiago

  Registry updated 2026-10-27

• NCT07293351

  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  Trial Treatment · Phase 1/2 · Bristol-Myers Squibb

  Bradfordhill, Santiago · Pontificia Universidad Catolica de Chile (PUC), Santiago · Santiago

  Registry updated 2026-10-23

• NCT07227402

  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Fundacion Arturo Lopez Perez (Site 0401), Santiago · Centro de Investigacion Clinica UC CICUC (Site 0402), Santiago · Oncocentro Valdivia (Site 0408), Valdivia

  Registry updated 2026-08-03

All Kidney cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error